These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

874 related items for PubMed ID: 30693750

  • 1. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
    Dong S, Sun Y, Liu J, Li L, He J, Zhang M, Ni P.
    ACS Appl Mater Interfaces; 2019 Mar 06; 11(9):8740-8748. PubMed ID: 30693750
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. One-Pot Synthesis of pH/Redox Responsive Polymeric Prodrug and Fabrication of Shell Cross-Linked Prodrug Micelles for Antitumor Drug Transportation.
    Li L, Li D, Zhang M, He J, Liu J, Ni P.
    Bioconjug Chem; 2018 Aug 15; 29(8):2806-2817. PubMed ID: 30005157
    [Abstract] [Full Text] [Related]

  • 5. Dual-Responsive Polyphosphoester-Doxorubicin Prodrug Containing a Diselenide Bond: Synthesis, Characterization, and Drug Delivery.
    Ma G, Liu J, He J, Zhang M, Ni P.
    ACS Biomater Sci Eng; 2018 Jul 09; 4(7):2443-2452. PubMed ID: 33435108
    [Abstract] [Full Text] [Related]

  • 6. Reduction-responsive amphiphilic polymeric prodrugs of camptothecin-polyphosphoester for cancer chemotherapy.
    Jin H, Sun M, Shi L, Zhu X, Huang W, Yan D.
    Biomater Sci; 2018 May 29; 6(6):1403-1413. PubMed ID: 29595843
    [Abstract] [Full Text] [Related]

  • 7. Fabrication of redox-responsive doxorubicin and paclitaxel prodrug nanoparticles with microfluidics for selective cancer therapy.
    Ma X, Özliseli E, Zhang Y, Pan G, Wang D, Zhang H.
    Biomater Sci; 2019 Jan 29; 7(2):634-644. PubMed ID: 30534690
    [Abstract] [Full Text] [Related]

  • 8. Codelivery of doxorubicin and camptothecin by dual-responsive unimolecular micelle-based β-cyclodextrin for enhanced chemotherapy.
    Gao YE, Bai S, Ma X, Zhang X, Hou M, Shi X, Huang X, Chen J, Wen F, Xue P, Kang Y, Xu Z.
    Colloids Surf B Biointerfaces; 2019 Nov 01; 183():110428. PubMed ID: 31415956
    [Abstract] [Full Text] [Related]

  • 9. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
    Xu Z, Wang D, Xu S, Liu X, Zhang X, Zhang H.
    Chem Asian J; 2014 Jan 01; 9(1):199-205. PubMed ID: 24136878
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Glutathione-triggered dual release of doxorubicin and camptothecin for highly efficient synergistic anticancer therapy.
    Li Y, Yang H, Yao J, Yu H, Chen X, Zhang P, Xiao C.
    Colloids Surf B Biointerfaces; 2018 Sep 01; 169():273-279. PubMed ID: 29787951
    [Abstract] [Full Text] [Related]

  • 12. Zwitterionic shielded polymeric prodrug with folate-targeting and pH responsiveness for drug delivery.
    Li L, Song Y, He J, Zhang M, Liu J, Ni P.
    J Mater Chem B; 2019 Feb 07; 7(5):786-795. PubMed ID: 32254853
    [Abstract] [Full Text] [Related]

  • 13. pH-responsive intramolecular FRET-based self-tracking polymer prodrug nanoparticles for real-time tumor intracellular drug release monitoring and imaging.
    Dong Y, Du P, Liu P.
    Int J Pharm; 2020 Oct 15; 588():119723. PubMed ID: 32755688
    [Abstract] [Full Text] [Related]

  • 14. Development of l-Tyrosine-Based Enzyme-Responsive Amphiphilic Poly(ester-urethane) Nanocarriers for Multiple Drug Delivery to Cancer Cells.
    Aluri R, Jayakannan M.
    Biomacromolecules; 2017 Jan 09; 18(1):189-200. PubMed ID: 28064504
    [Abstract] [Full Text] [Related]

  • 15. Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy.
    Zhang L, Qian M, Cui H, Zeng S, Wang J, Chen Q.
    ACS Appl Mater Interfaces; 2021 Feb 10; 13(5):6053-6068. PubMed ID: 33525873
    [Abstract] [Full Text] [Related]

  • 16. In situ DOX-calcium phosphate mineralized CPT-amphiphilic gelatin nanoparticle for intracellular controlled sequential release of multiple drugs.
    Li WM, Su CW, Chen YW, Chen SY.
    Acta Biomater; 2015 Mar 10; 15():191-9. PubMed ID: 25542535
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A GSH-Responsive Nanoprodrug System Based on Self-Assembly of Lactose Modified Camptothecin for Targeted Drug Delivery and Combination Chemotherapy.
    Hou C, Ma N, Shen Z, Chi G, Chao S, Pei Y, Chen L, Lu Y, Pei Z.
    Int J Nanomedicine; 2020 Mar 10; 15():10417-10424. PubMed ID: 33376329
    [Abstract] [Full Text] [Related]

  • 19. Dynamic core crosslinked camptothecin prodrug micelles with reduction sensitivity and boronic acid-mediated enhanced endocytosis: An intelligent tumor-targeted delivery nanoplatform.
    Huang Y, Zhang W, Xu Y, Zhu S, Wu Y, Chen T, Xiao Y, Lu W, Zhang X, Yu J.
    Int J Pharm; 2020 Apr 30; 580():119250. PubMed ID: 32209369
    [Abstract] [Full Text] [Related]

  • 20. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M, Gao YE, Shi X, Bai S, Ma X, Li B, Xiao B, Xue P, Kang Y, Xu Z.
    Acta Biomater; 2018 Sep 01; 77():228-239. PubMed ID: 30006314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.